Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
May 10, 2023 |
BACKGROUND
Despite high vaccine coverage and effectiveness, the incidence of symptomatic
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
been increasing in Israel. Whether the increasing incidence of infection is due
to waning immunity after the receipt of two doses of the BNT162b2 vaccine is
unclear.
METHODS
We conducted a 6-month longitudinal prospective study involving vaccinated
health care workers who were tested monthly for the presence of anti-spike IgG
and neutralizing antibodies. Linear mixed models were used to assess the dynamics
of antibody levels and to determine predictors of antibody levels at 6 months.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |